<DOC>
	<DOCNO>NCT01120106</DOCNO>
	<brief_summary>Calcium sensitizer drug Levosimendan may exert anti-ischemic effect addition positive inotropic anti-stunning effect mediate open ATP-sensitive potassium ( KATP ) channel . The aim study test myocardial protection effect peri-operative iv infusion Levosimendan cohort neonate affect transposition great artery undergo surgical correction arterial switch .</brief_summary>
	<brief_title>Levosimendan Administration Neonates With Transposition Great Arteries</brief_title>
	<detailed_description>Function myocardium neonates congenital heart disease may affect several factor post operative phase : congenital insufficiency , cardiopulmonary bypass low perfusion , ischemima cross-clamp phase , low cardiac output syndrome , systemic inflammation . Furthermore , neonates immature molecular mechanism lead calcium utilization inside myocytes . Calcium sensitizer drug Levosimendan may exert anti-ischemic effect addition positive inotropic anti-stunning effect mediate open ATP-sensitive potassium ( KATP ) channel . The aim study test inodilator myocardial protection effect peri-operative iv infusion 0.1 mcg/kg/min Levosimendan ( without previuos bolus ) cohort neonate affect transposition great artery undergo surgical correction arterial switch .</detailed_description>
	<mesh_term>Cardiac Output , Low</mesh_term>
	<mesh_term>Transposition Great Vessels</mesh_term>
	<mesh_term>Simendan</mesh_term>
	<criteria>neonate affect transposition great artery schedule elective surgery neonate affect transposition great artery schedule elective surgery ( urgent procedure , patient older 30 day )</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>30 Days</maximum_age>
	<verification_date>June 2012</verification_date>
	<keyword>levosimendan</keyword>
	<keyword>pediatric cardiac surgery</keyword>
	<keyword>low cardiac output syndrome</keyword>
	<keyword>transposition great artery</keyword>
</DOC>